Investor Presentaiton

3Q22 Business Results By Product (Unit: KRW bn) By Region Sales Breakdown (Unit: KRW bn) 519.0 496.4 2% 519.0 496.4 4% 5% 10% 5% LATAM 27% 11% 409.1 409.1 29% 13% -1% 11% Asia 4% 14% 6% 18% 13% 10% 30% 18% 17% 32% 44% 45% 61% 47% 43% 39% 37% 29% '21.3Q RemsimaⓇ / Inflectra '22.2Q TruximaⓇ RemsimaⓇ SC Chemical Note: Others included YuflymaⓇ, Regkirona®, Covid-19 kit and etc. '22.3Q '21.3Q '22.2Q '22.3Q HerzumaⓇ Others Europe N. America Growth market Investor Relations 2022 5

View entire presentation